Authors

• Sarah A. Marcus (ORCID: https://orcid.org/0000-0002-3795-0806)
• Laurent Humeau
• Albert J. Sylvester (ORCID: https://orcid.org/0000-0002-4087-9596)
• Suleimman Al‐Sweedan (ORCID: https://orcid.org/0000-0002-7779-9573)
• Matthew P. Morrow (ORCID: https://orcid.org/0000-0003-0258-6095)
• Kate E. Broderick (ORCID: https://orcid.org/0000-0003-2682-2363)
• Joseph Agnes
• Kathleen A. Walker
• Jean Boyer (ORCID: https://orcid.org/0000-0001-8699-0532)
• Stephanie Ramos (ORCID: https://orcid.org/0000-0002-5326-4937)
• Bernhards Ragama Ogutu (ORCID: https://orcid.org/0000-0002-0992-5654)
• Kimberly A. Kraynyak (ORCID: https://orcid.org/0000-0001-9233-8858)
• Josphat Kosgei (ORCID: https://orcid.org/0000-0002-0106-524X)
• David Liebowitz
• ShuPing Yang
• Elisabeth Gillespie
• Bonaventure Orizu
• Sahem S. Al-Ghraibeh

Institutions

• King Abdullah University Hospital (JO)
• United States Army Medical Research Directorate - Africa (KE)
• Kenya Medical Research Institute (KE)
• Reed Medical (United Kingdom) (GB)
• Inovio Pharmaceuticals (United States) (US)
• Yarmouk University (JO)

Publication Details

Journal

Frontiers in Immunology

Published

2025-11-14

DOI

https://doi.org/10.3389/fimmu.2025.1662923

Primary Topic

SARS-CoV-2 and COVID-19 Research

Type

article

Field-Weighted Citation Impact

0.00

Funders

• INOVIO Pharmaceuticals
• Coalition for Epidemic Preparedness Innovations